These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20345655)

  • 1. Overexpression of a single Leishmania major gene enhances parasite infectivity in vivo and in vitro.
    Reiling L; Chrobak M; Schmetz C; Clos J
    Mol Microbiol; 2010 Jun; 76(5):1175-90. PubMed ID: 20345655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leishmania major Hsp100 is required chiefly in the mammalian stage of the parasite.
    Hübel A; Krobitsch S; Hörauf A; Clos J
    Mol Cell Biol; 1997 Oct; 17(10):5987-95. PubMed ID: 9315657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spontaneous recovery of pathogenicity by Leishmania major hsp100-/- alters the immune response in mice.
    Reiling L; Jacobs T; Kroemer M; Gaworski I; Graefe S; Clos J
    Infect Immun; 2006 Nov; 74(11):6027-36. PubMed ID: 17057085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection.
    Zhang WW; Mendez S; Ghosh A; Myler P; Ivens A; Clos J; Sacks DL; Matlashewski G
    J Biol Chem; 2003 Sep; 278(37):35508-15. PubMed ID: 12829719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Phosphoenolpyruvate Carboxykinase Is a Key Metabolic Enzyme and Critical Virulence Factor of
    Barazandeh AF; Mou Z; Ikeogu N; Mejia EM; Edechi CA; Zhang WW; Alizadeh J; Hatch GM; Ghavami S; Matlashewski G; Marshall AJ; Uzonna JE
    J Immunol; 2021 Mar; 206(5):1013-1026. PubMed ID: 33462138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leishmania-encoded orthologs of macrophage migration inhibitory factor regulate host immunity to promote parasite persistence.
    Holowka T; Castilho TM; Garcia AB; Sun T; McMahon-Pratt D; Bucala R
    FASEB J; 2016 Jun; 30(6):2249-65. PubMed ID: 26956417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistence without pathology in phosphoglycan-deficient Leishmania major.
    Späth GF; Lye LF; Segawa H; Sacks DL; Turco SJ; Beverley SM
    Science; 2003 Aug; 301(5637):1241-3. PubMed ID: 12947201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Infection with arginase-deficient Leishmania major reveals a parasite number-dependent and cytokine-independent regulation of host cellular arginase activity and disease pathogenesis.
    Muleme HM; Reguera RM; Berard A; Azinwi R; Jia P; Okwor IB; Beverley S; Uzonna JE
    J Immunol; 2009 Dec; 183(12):8068-76. PubMed ID: 19923451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63.
    Connell ND; Medina-Acosta E; McMaster WR; Bloom BR; Russell DG
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11473-7. PubMed ID: 8265576
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response.
    Kébaïer C; Louzir H; Chenik M; Ben Salah A; Dellagi K
    Infect Immun; 2001 Aug; 69(8):4906-15. PubMed ID: 11447167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a compensatory mutant (lpg2-REV) of Leishmania major able to survive as amastigotes within macrophages without LPG2-dependent glycoconjugates and its significance to virulence and immunization strategies.
    Späth GF; Lye LF; Segawa H; Turco SJ; Beverley SM
    Infect Immun; 2004 Jun; 72(6):3622-7. PubMed ID: 15155672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of CRISPR/Cas9-Based Reverse Genetics in
    Adaui V; Kröber-Boncardo C; Brinker C; Zirpel H; Sellau J; Arévalo J; Dujardin JC; Clos J
    Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33007987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Leishmania expressed lipophosphoglycan interacts with Toll-like receptor (TLR)-2 to decrease TLR-9 expression and reduce anti-leishmanial responses.
    Srivastava S; Pandey SP; Jha MK; Chandel HS; Saha B
    Clin Exp Immunol; 2013 Jun; 172(3):403-9. PubMed ID: 23600828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of parasite encoded inhibitors of serine peptidases in early infection of macrophages with Leishmania major.
    Eschenlauer SC; Faria MS; Morrison LS; Bland N; Ribeiro-Gomes FL; DosReis GA; Coombs GH; Lima AP; Mottram JC
    Cell Microbiol; 2009 Jan; 11(1):106-20. PubMed ID: 19016791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.
    Ricardo-Carter C; Favila M; Polando RE; Cotton RN; Bogard Horner K; Condon D; Ballhorn W; Whitcomb JP; Yadav M; Geister RL; Schorey JS; McDowell MA
    Parasite Immunol; 2013 Dec; 35(12):409-20. PubMed ID: 23834512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SODB1 is essential for Leishmania major infection of macrophages and pathogenesis in mice.
    Davenport BJ; Martin CG; Beverley SM; Orlicky DJ; Vazquez-Torres A; Morrison TE
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006921. PubMed ID: 30372439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of virulence in NAD(P)H cytochrome b5 oxidoreductase deficient Leishmania major.
    Mukherjee A; Adhikari A; Das P; Biswas S; Mukherjee S; Adak S
    Biochem Biophys Res Commun; 2018 Sep; 503(1):371-377. PubMed ID: 29906460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leishmania LABCG1 and LABCG2 transporters are involved in virulence and oxidative stress: functional linkage with autophagy.
    Manzano JI; Perea A; León-Guerrero D; Campos-Salinas J; Piacenza L; Castanys S; Gamarro F
    Parasit Vectors; 2017 May; 10(1):267. PubMed ID: 28558770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coencapsulation of CpG oligodeoxynucleotides with recombinant Leishmania major stress-inducible protein 1 in liposome enhances immune response and protection against leishmaniasis in immunized BALB/c mice.
    Badiee A; Jaafari MR; Samiei A; Soroush D; Khamesipour A
    Clin Vaccine Immunol; 2008 Apr; 15(4):668-74. PubMed ID: 18235040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic changes associated with deletion and overexpression of a stage-regulated gene family in Leishmania.
    McKean PG; Denny PW; Knuepfer E; Keen JK; Smith DF
    Cell Microbiol; 2001 Aug; 3(8):511-23. PubMed ID: 11488813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.